ASH announces four new executive committee members
Click Here to Manage Email Alerts
ASH announced the election of four new members to its executive committee.
Robert A. Brodsky, MD, will serve a 1-year term as vice president, followed by successive terms as president-elect and president.
Brodsky is director of the division of hematology at Johns Hopkins School of Medicine. He also is professor of medicine and oncology, as well as director of the physician-scientist pathway for the Osler Medical Training Program.
Brodsky’s research interests include bone marrow failure states, paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, antiphospholipid antibody syndrome and bone marrow transplantation for nonmalignant diseases.
“My experiences working on various ASH programs have provided me with a deep appreciation and understanding of the society’s mission to promote research, clinical care, training and advocacy in hematology,” Brodsky said in an ASH-issued press release. “As I look toward the next few years, recruiting, inspiring, training and mentoring the next generation of hematologists is of clear importance. We need to recruit a diverse, inclusive workforce to treat hematology patients and ensure that early-career investigators can access research funding that allows them to pursue clinical and laboratory-based research.”
Cynthia E. Dunbar, MD, will serve a 4-year term as secretary.
Dunbar — who is completing her term as an ASH councilor — is chief of the translational stem cell biology branch within the NHLBI’s intramural research program.
Her research focus areas include natural killer cell biology, hematopoiesis, hematopoietic stem cell and chimeric antigen receptor T-cell gene therapies, and congenital and acquired bone marrow failure syndromes.
Jamile M. Shammo, MD, FASCP, FACP, and Betty S. Pace, MD, will serve 4-year terms as ASH councilors.
Shammo is professor of medicine and pathology in the hematology and stem cell transplantation section of Rush University Medical Center’s division of hematology/oncology. Her research focuses on myeloproliferative neoplasms, myelodysplastic syndrome and bone marrow failure.
Pace is professor of pediatrics and Francis J. Tedesco distinguished chair of pediatric hematology/oncology at Medical College of Georgia. Her research focuses on sickle cell disease, globin gene regulation, training junior investigators and increasing diversity in the hematology workforce.
All four new executive committee members will begin their terms after this year’s ASH Annual Meeting & Exposition, which will be presented in a virtual format Dec. 5-8.
“As our field faces unprecedented challenges resulting from the pandemic, ASH members need dedicated, visionary leaders who will offer creative solutions to ensure the society continues to support important research, cultivate a strong workforce and advocate on behalf of hematology patients worldwide,” ASH President Stephanie Lee, MD, MPH, member and associate director of the clinical research division and David and Patricia Giuliani/Oliver Press endowed chair in cancer research at Fred Hutchinson Cancer Research Center, said in the release. “Drs. Brodsky, Dunbar, Shammo and Pace bring a wealth of ASH experience and hematology expertise, and I know the society and our field will continue to thrive under their leadership.”
Click Here to Manage Email Alerts